Global Gastrointestinal Disorder Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 109

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

According to our (Global Info Research) latest study, the global Gastrointestinal Disorder Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gastrointestinal Disorder Therapeutics industry chain, the market status of Hospitals (Irritable Bowel Syndrome (IBS), Chronic Constipation (CC)), Clinics (Irritable Bowel Syndrome (IBS), Chronic Constipation (CC)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Disorder Therapeutics.

Regionally, the report analyzes the Gastrointestinal Disorder Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Disorder Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gastrointestinal Disorder Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Disorder Therapeutics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Irritable Bowel Syndrome (IBS), Chronic Constipation (CC)).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Disorder Therapeutics market.

Regional Analysis: The report involves examining the Gastrointestinal Disorder Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Disorder Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gastrointestinal Disorder Therapeutics:
Company Analysis: Report covers individual Gastrointestinal Disorder Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Disorder Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Disorder Therapeutics. It assesses the current state, advancements, and potential future developments in Gastrointestinal Disorder Therapeutics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Disorder Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gastrointestinal Disorder Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Irritable Bowel Syndrome (IBS)
Chronic Constipation (CC)
Ulcerative Colitis (UC)

Market segment by Application
Hospitals
Clinics
Others

Market segment by players, this report covers
AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Disorder Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Disorder Therapeutics, with revenue, gross margin and global market share of Gastrointestinal Disorder Therapeutics from 2019 to 2024.
Chapter 3, the Gastrointestinal Disorder Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Disorder Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Disorder Therapeutics.
Chapter 13, to describe Gastrointestinal Disorder Therapeutics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Disorder Therapeutics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gastrointestinal Disorder Therapeutics by Type
        1.3.1 Overview: Global Gastrointestinal Disorder Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type in 2023
        1.3.3 Irritable Bowel Syndrome (IBS)
        1.3.4 Chronic Constipation (CC)
        1.3.5 Ulcerative Colitis (UC)
    1.4 Global Gastrointestinal Disorder Therapeutics Market by Application
        1.4.1 Overview: Global Gastrointestinal Disorder Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Others
    1.5 Global Gastrointestinal Disorder Therapeutics Market Size & Forecast
    1.6 Global Gastrointestinal Disorder Therapeutics Market Size and Forecast by Region
        1.6.1 Global Gastrointestinal Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gastrointestinal Disorder Therapeutics Market Size by Region, (2019-2030)
        1.6.3 North America Gastrointestinal Disorder Therapeutics Market Size and Prospect (2019-2030)
        1.6.4 Europe Gastrointestinal Disorder Therapeutics Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size and Prospect (2019-2030)
        1.6.6 South America Gastrointestinal Disorder Therapeutics Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gastrointestinal Disorder Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Product and Solutions
        2.1.4 AstraZeneca Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 AstraZeneca Recent Developments and Future Plans
    2.2 Takeda Pharmaceutical
        2.2.1 Takeda Pharmaceutical Details
        2.2.2 Takeda Pharmaceutical Major Business
        2.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product and Solutions
        2.2.4 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Takeda Pharmaceutical Recent Developments and Future Plans
    2.3 Johnson & Johnson
        2.3.1 Johnson & Johnson Details
        2.3.2 Johnson & Johnson Major Business
        2.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Product and Solutions
        2.3.4 Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Johnson & Johnson Recent Developments and Future Plans
    2.4 Eisai
        2.4.1 Eisai Details
        2.4.2 Eisai Major Business
        2.4.3 Eisai Gastrointestinal Disorder Therapeutics Product and Solutions
        2.4.4 Eisai Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Eisai Recent Developments and Future Plans
    2.5 Abbott Laboratories
        2.5.1 Abbott Laboratories Details
        2.5.2 Abbott Laboratories Major Business
        2.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product and Solutions
        2.5.4 Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Abbott Laboratories Recent Developments and Future Plans
    2.6 Salix Pharmaceuticals
        2.6.1 Salix Pharmaceuticals Details
        2.6.2 Salix Pharmaceuticals Major Business
        2.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Solutions
        2.6.4 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Salix Pharmaceuticals Recent Developments and Future Plans
    2.7 Bausch Health
        2.7.1 Bausch Health Details
        2.7.2 Bausch Health Major Business
        2.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Product and Solutions
        2.7.4 Bausch Health Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bausch Health Recent Developments and Future Plans
    2.8 Allergan
        2.8.1 Allergan Details
        2.8.2 Allergan Major Business
        2.8.3 Allergan Gastrointestinal Disorder Therapeutics Product and Solutions
        2.8.4 Allergan Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Allergan Recent Developments and Future Plans
    2.9 Bayer
        2.9.1 Bayer Details
        2.9.2 Bayer Major Business
        2.9.3 Bayer Gastrointestinal Disorder Therapeutics Product and Solutions
        2.9.4 Bayer Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Bayer Recent Developments and Future Plans
    2.10 UCB
        2.10.1 UCB Details
        2.10.2 UCB Major Business
        2.10.3 UCB Gastrointestinal Disorder Therapeutics Product and Solutions
        2.10.4 UCB Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 UCB Recent Developments and Future Plans
    2.11 AbbVie
        2.11.1 AbbVie Details
        2.11.2 AbbVie Major Business
        2.11.3 AbbVie Gastrointestinal Disorder Therapeutics Product and Solutions
        2.11.4 AbbVie Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 AbbVie Recent Developments and Future Plans
    2.12 GlaxoSmithKline
        2.12.1 GlaxoSmithKline Details
        2.12.2 GlaxoSmithKline Major Business
        2.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product and Solutions
        2.12.4 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 GlaxoSmithKline Recent Developments and Future Plans
    2.13 Astellas Pharma
        2.13.1 Astellas Pharma Details
        2.13.2 Astellas Pharma Major Business
        2.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Product and Solutions
        2.13.4 Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Astellas Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Disorder Therapeutics Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gastrointestinal Disorder Therapeutics by Company Revenue
        3.2.2 Top 3 Gastrointestinal Disorder Therapeutics Players Market Share in 2023
        3.2.3 Top 6 Gastrointestinal Disorder Therapeutics Players Market Share in 2023
    3.3 Gastrointestinal Disorder Therapeutics Market: Overall Company Footprint Analysis
        3.3.1 Gastrointestinal Disorder Therapeutics Market: Region Footprint
        3.3.2 Gastrointestinal Disorder Therapeutics Market: Company Product Type Footprint
        3.3.3 Gastrointestinal Disorder Therapeutics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Disorder Therapeutics Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2030)
    6.2 North America Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2030)
    6.3 North America Gastrointestinal Disorder Therapeutics Market Size by Country
        6.3.1 North America Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2030)
        6.3.2 United States Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        6.3.3 Canada Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2030)
    7.2 Europe Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2030)
    7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Country
        7.3.1 Europe Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2030)
        7.3.2 Germany Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        7.3.3 France Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        7.3.5 Russia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        7.3.6 Italy Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Region (2019-2030)
        8.3.2 China Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        8.3.3 Japan Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        8.3.5 India Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        8.3.7 Australia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2030)
    9.2 South America Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2030)
    9.3 South America Gastrointestinal Disorder Therapeutics Market Size by Country
        9.3.1 South America Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)
        10.3.4 UAE Gastrointestinal Disorder Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gastrointestinal Disorder Therapeutics Market Drivers
    11.2 Gastrointestinal Disorder Therapeutics Market Restraints
    11.3 Gastrointestinal Disorder Therapeutics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gastrointestinal Disorder Therapeutics Industry Chain
    12.2 Gastrointestinal Disorder Therapeutics Upstream Analysis
    12.3 Gastrointestinal Disorder Therapeutics Midstream Analysis
    12.4 Gastrointestinal Disorder Therapeutics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Disorder Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gastrointestinal Disorder Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gastrointestinal Disorder Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gastrointestinal Disorder Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 6. AstraZeneca Major Business
    Table 7. AstraZeneca Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 8. AstraZeneca Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. AstraZeneca Recent Developments and Future Plans
    Table 10. Takeda Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 11. Takeda Pharmaceutical Major Business
    Table 12. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 13. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Takeda Pharmaceutical Recent Developments and Future Plans
    Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 16. Johnson & Johnson Major Business
    Table 17. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 18. Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Johnson & Johnson Recent Developments and Future Plans
    Table 20. Eisai Company Information, Head Office, and Major Competitors
    Table 21. Eisai Major Business
    Table 22. Eisai Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 23. Eisai Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Eisai Recent Developments and Future Plans
    Table 25. Abbott Laboratories Company Information, Head Office, and Major Competitors
    Table 26. Abbott Laboratories Major Business
    Table 27. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 28. Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Abbott Laboratories Recent Developments and Future Plans
    Table 30. Salix Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 31. Salix Pharmaceuticals Major Business
    Table 32. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 33. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Salix Pharmaceuticals Recent Developments and Future Plans
    Table 35. Bausch Health Company Information, Head Office, and Major Competitors
    Table 36. Bausch Health Major Business
    Table 37. Bausch Health Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 38. Bausch Health Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Bausch Health Recent Developments and Future Plans
    Table 40. Allergan Company Information, Head Office, and Major Competitors
    Table 41. Allergan Major Business
    Table 42. Allergan Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 43. Allergan Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Allergan Recent Developments and Future Plans
    Table 45. Bayer Company Information, Head Office, and Major Competitors
    Table 46. Bayer Major Business
    Table 47. Bayer Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 48. Bayer Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Bayer Recent Developments and Future Plans
    Table 50. UCB Company Information, Head Office, and Major Competitors
    Table 51. UCB Major Business
    Table 52. UCB Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 53. UCB Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. UCB Recent Developments and Future Plans
    Table 55. AbbVie Company Information, Head Office, and Major Competitors
    Table 56. AbbVie Major Business
    Table 57. AbbVie Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 58. AbbVie Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. AbbVie Recent Developments and Future Plans
    Table 60. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 61. GlaxoSmithKline Major Business
    Table 62. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 63. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. GlaxoSmithKline Recent Developments and Future Plans
    Table 65. Astellas Pharma Company Information, Head Office, and Major Competitors
    Table 66. Astellas Pharma Major Business
    Table 67. Astellas Pharma Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 68. Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Astellas Pharma Recent Developments and Future Plans
    Table 70. Global Gastrointestinal Disorder Therapeutics Revenue (USD Million) by Players (2019-2024)
    Table 71. Global Gastrointestinal Disorder Therapeutics Revenue Share by Players (2019-2024)
    Table 72. Breakdown of Gastrointestinal Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Gastrointestinal Disorder Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 74. Head Office of Key Gastrointestinal Disorder Therapeutics Players
    Table 75. Gastrointestinal Disorder Therapeutics Market: Company Product Type Footprint
    Table 76. Gastrointestinal Disorder Therapeutics Market: Company Product Application Footprint
    Table 77. Gastrointestinal Disorder Therapeutics New Market Entrants and Barriers to Market Entry
    Table 78. Gastrointestinal Disorder Therapeutics Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Gastrointestinal Disorder Therapeutics Consumption Value (USD Million) by Type (2019-2024)
    Table 80. Global Gastrointestinal Disorder Therapeutics Consumption Value Share by Type (2019-2024)
    Table 81. Global Gastrointestinal Disorder Therapeutics Consumption Value Forecast by Type (2025-2030)
    Table 82. Global Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2024)
    Table 83. Global Gastrointestinal Disorder Therapeutics Consumption Value Forecast by Application (2025-2030)
    Table 84. North America Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
    Table 85. North America Gastrointestinal Disorder Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
    Table 86. North America Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. North America Gastrointestinal Disorder Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. North America Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
    Table 89. North America Gastrointestinal Disorder Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
    Table 90. Europe Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
    Table 91. Europe Gastrointestinal Disorder Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
    Table 92. Europe Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
    Table 93. Europe Gastrointestinal Disorder Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
    Table 94. Europe Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Gastrointestinal Disorder Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
    Table 97. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
    Table 98. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
    Table 99. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
    Table 100. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
    Table 101. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
    Table 102. South America Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
    Table 103. South America Gastrointestinal Disorder Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
    Table 104. South America Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
    Table 105. South America Gastrointestinal Disorder Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
    Table 106. South America Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
    Table 107. South America Gastrointestinal Disorder Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
    Table 108. Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
    Table 110. Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
    Table 111. Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
    Table 113. Middle East & Africa Gastrointestinal Disorder Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
    Table 114. Gastrointestinal Disorder Therapeutics Raw Material
    Table 115. Key Suppliers of Gastrointestinal Disorder Therapeutics Raw Materials
List of Figures
    Figure 1. Gastrointestinal Disorder Therapeutics Picture
    Figure 2. Global Gastrointestinal Disorder Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type in 2023
    Figure 4. Irritable Bowel Syndrome (IBS)
    Figure 5. Chronic Constipation (CC)
    Figure 6. Ulcerative Colitis (UC)
    Figure 7. Global Gastrointestinal Disorder Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application in 2023
    Figure 9. Hospitals Picture
    Figure 10. Clinics Picture
    Figure 11. Others Picture
    Figure 12. Global Gastrointestinal Disorder Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Gastrointestinal Disorder Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Gastrointestinal Disorder Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Region in 2023
    Figure 17. North America Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Gastrointestinal Disorder Therapeutics Revenue Share by Players in 2023
    Figure 23. Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Gastrointestinal Disorder Therapeutics Market Share in 2023
    Figure 25. Global Top 6 Players Gastrointestinal Disorder Therapeutics Market Share in 2023
    Figure 26. Global Gastrointestinal Disorder Therapeutics Consumption Value Share by Type (2019-2024)
    Figure 27. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Type (2025-2030)
    Figure 28. Global Gastrointestinal Disorder Therapeutics Consumption Value Share by Application (2019-2024)
    Figure 29. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Application (2025-2030)
    Figure 30. North America Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Gastrointestinal Disorder Therapeutics Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Gastrointestinal Disorder Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 64. Gastrointestinal Disorder Therapeutics Market Drivers
    Figure 65. Gastrointestinal Disorder Therapeutics Market Restraints
    Figure 66. Gastrointestinal Disorder Therapeutics Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Gastrointestinal Disorder Therapeutics in 2023
    Figure 69. Manufacturing Process Analysis of Gastrointestinal Disorder Therapeutics
    Figure 70. Gastrointestinal Disorder Therapeutics Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma

Product Tags

Gastrointestinal Disorder Therapeutics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>